These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 11987154)

  • 1. Quantitative microbubble enhanced transrectal ultrasound as a tool for monitoring hormonal treatment of prostate carcinoma.
    Eckersley RJ; Sedelaar JP; Blomley MJ; Wijkstra H; deSouza NM; Cosgrove DO; de la Rosette JJ
    Prostate; 2002 Jun; 51(4):256-67. PubMed ID: 11987154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does the adjunct of ecographic contrast medium Levovist improve the detection rate of prostate cancer?
    Pepe P; Patanè D; Panella P; Aragona F
    Prostate Cancer Prostatic Dis; 2003; 6(2):159-62. PubMed ID: 12806376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The correlations between color Doppler using a contrast medium and the neoangiogenesis of small prostatic carcinomas].
    Lagalla R; Caruso G; Urso R; Bizzini G; Marasà L; Miceli V
    Radiol Med; 2000 Apr; 99(4):270-5. PubMed ID: 10884828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of prostate cancer with a microbubble ultrasound contrast agent.
    Frauscher F; Klauser A; Halpern EJ; Horninger W; Bartsch G
    Lancet; 2001 Jun; 357(9271):1849-50. PubMed ID: 11410195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The value of contrast enhanced power Doppler ultrasonography in differentiating hypoehoic lesions in the peripheral zone of prostate.
    Karaman CZ; Unsal A; Akdilli A; Taşkin F; Erol H
    Eur J Radiol; 2005 Apr; 54(1):148-55. PubMed ID: 15797304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Staging of prostate cancer. Accuracy of transrectal ultrasound enhanced by prostate-specific antigen.
    Wolf JS; Shinohara K; Narayan P
    Br J Urol; 1992 Nov; 70(5):534-41. PubMed ID: 1281724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PSA evolution: a prognostic factor during treatment of advanced prostatic carcinoma with total androgen blockade. Data from a Belgian multicentric study of 546 patients.
    Oosterlinck W; Mattelaer J; Casselman J; Van Velthoven R; Derde MP; Kaufman L
    Acta Urol Belg; 1997 Oct; 65(3):63-71. PubMed ID: 9421938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis of prostate cancer: comparison of serum prostate specific antigen, digital rectal examination and transrectal ultrasonography.
    Tsui KH; Chang PL; Wang TM; Hsieh ML
    Changgeng Yi Xue Za Zhi; 1997 Mar; 20(1):23-8. PubMed ID: 9178589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate-specific antigen half-life and pretreatment prostate-specific antigen: crucial predictors for prostate-specific antigen trend in delayed-combined androgen blockade therapy.
    Soga N; Onishi T; Arima K; Sugimura Y
    Int J Urol; 2007 Mar; 14(3):192-6; discussion 197. PubMed ID: 17430253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diethylstilboestrol versus bicalutamide in hormone refractory prostate carcinoma: a prospective randomized trial.
    Manikandan R; Srirangam SJ; Pearson E; Brown SC; O'Reilly P; Collins GN
    Urol Int; 2005; 75(3):217-21. PubMed ID: 16215308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can Power Doppler enhanced transrectal ultrasound guided biopsy improve prostate cancer detection on first and repeat prostate biopsy?
    Remzi M; Dobrovits M; Reissigl A; Ravery V; Waldert M; Wiunig C; Fong YK; Djavan B;
    Eur Urol; 2004 Oct; 46(4):451-6. PubMed ID: 15363559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Undetectable prostate specific antigen at 6-12 months: a new marker for early success in hormonally treated patients after prostate brachytherapy.
    Miller N; Smolkin ME; Bissonette E; Theodorescu D
    Cancer; 2005 Jun; 103(12):2499-506. PubMed ID: 15852361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of contrast enhanced color Doppler targeted biopsy to conventional systematic biopsy: impact on Gleason score.
    Mitterberger M; Pinggera GM; Horninger W; Bartsch G; Strasser H; Schäfer G; Brunner A; Halpern EJ; Gradl J; Pallwein L; Frauscher F
    J Urol; 2007 Aug; 178(2):464-8; discussion 468. PubMed ID: 17561137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison between color power Doppler ultrasound with echo-enhancer and spiral computed tomography in the evaluation of hepatocellular carcinoma vascularization before and after ablation procedures.
    Cedrone A; Pompili M; Sallustio G; Lorenzelli GP; Gasbarrini G; Rapaccini GL
    Am J Gastroenterol; 2001 Jun; 96(6):1854-9. PubMed ID: 11419839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of a microbubble contrast agent on breast tumors: computer-assisted quantitative assessment with color Doppler US--early experience.
    Huber S; Helbich T; Kettenbach J; Dock W; Zuna I; Delorme S
    Radiology; 1998 Aug; 208(2):485-9. PubMed ID: 9680580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical utility of available diagnostic tests in prostatic carcinoma. Results of 500 biopsies. II. Rectal palpation, PSA, and transrectal echography].
    Rodríguez Rodríguez R; Mayayo Dehesa T; Galbis Sanjuan F; Jiménez Cidre M; Burgos Revilla FJ; Gómez dos Santos V; García González R
    Arch Esp Urol; 1997 May; 50(4):339-45. PubMed ID: 9313042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transrectal broadband-Doppler sonography with intravenous contrast medium administration for prostate imaging and biopsy in men with an elevated PSA value and previous negative biopsies.
    Taymoorian K; Thomas A; Slowinski T; Khiabanchian M; Stephan C; Lein M; Deger S; Lenk S; Loening SA; Fischer T
    Anticancer Res; 2007; 27(6C):4315-20. PubMed ID: 18214038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrast-enhanced transrectal color doppler ultrasonography (TRCDUS) for assessment of angiogenesis in prostate cancer.
    Strohmeyer D; Frauscher F; Klauser A; Recheis W; Eibl G; Horninger W; Steiner H; Volgger H; Bartsch G
    Anticancer Res; 2001; 21(4B):2907-13. PubMed ID: 11712785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PSA velocity and PSA slope.
    Benecchi L
    Prostate Cancer Prostatic Dis; 2006; 9(2):169-72. PubMed ID: 16568147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of prostate carcinoma: accuracy of gray-scale and color Doppler US and serum markers.
    Kuligowska E; Barish MA; Fenlon HM; Blake M
    Radiology; 2001 Sep; 220(3):757-64. PubMed ID: 11526279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.